lymphoglobuline

equine anti-human thymocyte immunoglobulin used as an immunosuppressive agent against human T lymphocytes for treatment of graft rejection or aplastic anemia

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Asaka, M: 1 article (10/2001)
2.	Chiba, K: 1 article (10/2001)
3.	Hashino, S: 1 article (10/2001)
4.	Izumiyama, K: 1 article (10/2001)
5.	Suzuki, S: 1 article (10/2001)
6.	Takahata, M: 1 article (10/2001)
7.	Chen, S: 1 article (04/2000)
8.	Guan, G: 1 article (04/2000)
9.	He, Y: 1 article (04/2000)
10.	Qian, X: 1 article (04/2000)

Related Diseases

1.	Graft vs Host Disease (Graft-Versus-Host Disease) 04/01/2000 - "Pre-transplant conditions included Busulfan 16mg/kg, cyclophosphamide 200mg/kg and lymphoglobuline 88mg/kg. Cyclosporine and methotrexate were used for prevention of graft-versus-host disease(GVHD). "
2.	Aplastic Anemia (Anemia, Hypoplastic) 10/01/2001 - "A 21-year-old woman with severe aplastic anemia received an allogeneic bone marrow transplant (allo-BMT) from an HLA-matched and ABO-matched sibling donor after conditioning with cyclophosphamide, rabbit ATG (Lymphoglobuline; Aventis-Pharma), and total lymphoid irradiation. "

Related Drugs and Biologics

1.	Cyclophosphamide (Cytoxan)
2.	Cyclosporine (Ciclosporin)
3.	Methotrexate (Mexate)
4.	Busulfan (Busulfex)
5.	thymoglobulin

Related Therapies and Procedures

1.	Lymphatic Irradiation